Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Managing Editor Europe
{A1EF0A44-49EE-467F-964C-F748991F5552}
+3 year(s) experience
Scrip
By Kevin Grogan 13 Jun 2019
Novartis’s erstwhile head of pharma will be tasked with making the French drug maker more agile on the commercial and research fronts and expanding its digital capabilities.
Topic Business strategies Strategy
Scrip
By Kevin Grogan 23 May 2019
With US drug pricing pressures and generic and biosimilar competition weighing on big pharma, new launches and brisk business in China have been providing a silver lining. Scrip writers analyze the industry landscape in light of the first-quarter results.
Topic Business strategies
Scrip
By Kevin Grogan 15 May 2019
Scrip editors will dissect Q1 sales and earnings reports of top pharma companies and focus on key trends, developments, and projected future impact.
Scrip
By Kevin Grogan 07 Mar 2019
The German group believes it is going to be at the forefront of development in the cell and gene therapy space but is worried that Europe is failing to recognize the value that the pharma industry and its new technologies can create for society.
Topic Cell and gene therapy
Scrip
By Kevin Grogan 21 Feb 2019
When buying Loxo, Lilly highlighted the importance of LOXO-292, a first-in-class oral RET inhibitor, rather than the already-approved Vitrakvi, perhaps knowing that partner Bayer was going to be exercising an option to take full control of the TRK inhibitor.
Scrip
18 Oct 2019
Scrip
18 Oct 2019
Scrip
16 Oct 2019
Scrip
15 Oct 2019
Scrip
11 Oct 2019
Scrip
10 Oct 2019
Scrip
09 Oct 2019
Scrip
08 Oct 2019
Scrip
07 Oct 2019
Scrip
04 Oct 2019
Scrip
02 Oct 2019
Scrip
01 Oct 2019
Scrip
30 Sep 2019
Scrip
27 Sep 2019
Scrip
26 Sep 2019
